Federico Riccardi Sirtori

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1<i>H</i>-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy

Gianluca Papeo, Helena Posteri, Daniela Borghi et al. · Journal of Medicinal Chemistry · 2015 · 143 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma

Serena Pellegatta, Lorella Valletta, Cristina Corbetta et al. · Acta Neuropathologica Communications · 2015 · 119 citations · Full text

Medicine, Molecular Biology, Oncology +17

Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity Relationships

Paolo Polucci, Paola Magnaghi, Mauro Angiolini et al. · Journal of Medicinal Chemistry · 2012 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

[GdPCP2A(H₂O)₂]^-: A Paramagnetic Contrast Agent Designed for Improved Applications in Magnetic Resonance Imaging

Silvio Aime, Mauro Botta, Luca Frullano et al. · Journal of Medicinal Chemistry · 2000 · 80 citations

Medicine, Medicinal Chemistry, Pharmacology +17

A fully automated method for accurate mass determination using high‐performance liquid chromatography with a quadrupole/orthogonal acceleration time‐of‐flight mass spectrometer

Maristella Colombo, Federico Riccardi Sirtori, Vincenzo Rizzo · Rapid Communications in Mass Spectrometry · 2004 · 69 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +17